Navigation Links
Simmons Law Firm Presents Second 'Miles for Meso' Walk/Run Fundraiser

EAST ALTON, Ill., Sept. 30 /PRNewswire/ -- The Simmons firm, a leading national law firm in the fight against mesothelioma and other asbestos-related diseases, will present the second Miles for Meso 5K run/walk on Sunday, October 11, in University City, at 9 a.m. Registrations are being accepted at

The Simmons firm sponsored the first annual Miles for Meso event September 26 in Alton, Ill. Nearly 500 runners and walkers registered, and through matching donations by the Simmons firm raised approximately $30,000.

"We're excited that so many people, with so many options to run or walk in events for other causes, supported Miles for Meso," said Chairman and CEO John Simmons. "We really were pleased by the support of our Metro East neighbors. Now, with the help of our friend Julie Gundlach, we hope to achieve the same results in St. Louis. Our simple goals are to make people aware of mesothelioma and generate funds for critical research."

Gundlach, who has been living with mesothelioma cancer since 2006 and participated in the Alton event, is helping lead the St. Louis event. Ghisallo Running is helping to coordinate the event.

Gundlach plans to run in the 5K for runners and walkers that will begin at Centennial Commons. "Unfortunately, mesothelioma is now everyone's problem," she said. "It's my hope that, through events like this, people come to start to understand that this is a preventable disease, and that we need the help of everyone to educate and raise money for research."

Mesothelioma is a rare and aggressive cancer caused by exposure to asbestos. The Simmons firm's sponsorship includes matching and donating 100 percent of all entry fees to the Mesothelioma Applied Research Foundation, a national nonprofit dedicated to funding critical research for better treatment options and, ultimately, to find a cure for mesothelioma.

The "Miles for Meso" event is open to participants of all ages. Prizes will be awarded to the top runners: the top three finishers in the men's and women's categories, including gift certificates to the Ghisallo's Running Store, credit towards a membership to Centennial Commons, and more. All participants will be eligible for five $100 drawings and other giveaways. The registration fee is $15 on or before October 1, $20 after October 1, and $25 for registration onsite the day of the race.

"The need for mesothelioma education, awareness, and research has never been more urgent," Simmons said. "Our firm is committed to funding research and building awareness about the disease so that we can assist in providing the needed critical help for families throughout Illinois, Missouri, and the entire country."

About Simmons Browder Gianaris Angelides & Barnerd LLC

The Simmons firm is a leading national law firm in the fight against mesothelioma. With offices in Illinois, Missouri and California, the firm has represented thousands of patients and families affected by mesothelioma from all across the country. The Simmons firm is passionate about improving the lives of victims of mesothelioma and asbestos-related illnesses and has pledged over $15 million to cancer research. The firm also has practice areas in intellectual property, pharmaceutical litigation, and business litigation.

SOURCE Simmons Browder Gianaris Angelides & Barnerd LLC

SOURCE Simmons Browder Gianaris Angelides & Barnerd LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. R. P. Simmons Family Foundation Pledges $2 Million for New Childrens Hospital of Pittsburgh of UPMC Campus
2. A Best-Kept Secret of Your Teen: They Really Do Care What You Think, Simmons College Study Shows
3. MultiVu Video Feed: Richard Simmons and Ocean Spray Team-Up to Solve
4. On World AIDS Day, Russell Simmons and Special Guests Attended Empowerment for Africa Dinner
5. Simmons Celebrates Earth Day by Encouraging Consumers To "Sleep Green"
6. Children Uniting Nations, Russell Simmons, Mos Def, David Archuleta, Terrence Howard, Gabrielle Union, Vivica Fox, Elise Neal, and Shawn King - Visit Nations Capitol to Promote Student Mentoring and Change for Child Welfare
7. Michael Simmons, DMD presented a poster at the American Academy of Dental Sleep Medicine Meeting
8. Decorated Trial Attorney Conard Metcalf Joins Simmons Firm as Of Counsel
9. Michael Simmons, DMD to speak at California Dental Association Meeting
10. The Simmons Firm to Host Midwest Asbestos Litigation Conference
11. Updated GOLD report presents new understandings in diagnosis, treatment and prevention of COPD
Post Your Comments:
(Date:12/1/2015)... NY (PRWEB) , ... December 01, 2015 , ... ... in the 1980s we have seen vast improvements in scientific research and discoveries, ... significant strides, providing increased hope and relief to those affected by HIV/AIDS. Mediaplanet’s ...
(Date:12/1/2015)... New York, NY (PRWEB) , ... December 01, ... ... cause of non-traumatic limb amputations in the United States. Podiatrists are well aware ... (failure to adopt therapeutic behaviors) are often catastrophic contributors to diseases of the ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Imaging Inc. (“Visage”), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), ... at the Radiological Society of North America (RSNA) 2015 annual meeting through December ...
(Date:12/1/2015)... ... December 01, 2015 , ... Lutronic, a leading innovator of aesthetic and ... to the devices for sale in the United States. Clarity is a Superior ... nm Nd:YAG lasers, into a single platform that is easy to own and operate. ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... and SACC-USA through membership and leadership since 2008. Gary Bruce, President of PartnerTech ... . Gary has spent a significant amount of time in Sweden since joining ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... --  MabVax Therapeutics Holdings, Inc . (OTCQB: MBVX), a ... an Investigational New Drug Application (IND) with the U.S. ... fully human antibody product HuMab 5B1 as a therapeutic ... the Phase I clinical trial early in 2016. ... planned Phase I trial will evaluate the safety, tolerability ...
(Date:12/1/2015)... 2015  Booth #3506 – Claymount is featuring its full ... of the Radiological Society of North America ... Based in the Netherlands , Claymount is ... (NYSE: VAR ) and is one of the world,s ... state automatic exposure control systems for controlling dose during medical ...
(Date:12/1/2015)... , Dec. 1, 2015  Lexicon Pharmaceuticals, ... that top-line data from its TELECAST Phase ... in treating carcinoid syndrome in cancer patients ... clinical benefit observed in its pivotal TELESTAR ... a companion to TELESTAR primarily to provide ...
Breaking Medicine Technology: